GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.
- DOI
- 10.1177/13524585251405101
- Published
- 2026 Feb
- Container
- Multiple sclerosis (Houndmills, Basingstoke, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13524585251405101,
title = {GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.},
author = {Miller A and Cohen JA and Karni A and Popper L and Bleich Kimelman N and Rubnov S and Danon U and Marom E and Boyko A and Zivadinov R and Berger JR and Bar-Or A and Kolb H},
year = {2026},
journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
doi = {10.1177/13524585251405101},
url = {https://doi.org/10.1177/13524585251405101}
}RIS
TY - JOUR TI - GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial. AU - Miller A AU - Cohen JA AU - Karni A AU - Popper L AU - Bleich Kimelman N AU - Rubnov S AU - Danon U AU - Marom E AU - Boyko A AU - Zivadinov R AU - Berger JR AU - Bar-Or A AU - Kolb H PY - 2026 JO - Multiple sclerosis (Houndmills, Basingstoke, England) DO - 10.1177/13524585251405101 UR - https://doi.org/10.1177/13524585251405101 ER -
APA
A, M., JA, C., A, K., L, P., N, B. K., S, R., U, D., E, M., A, B., R, Z., JR, B., A, B., & H, K. (2026). GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.. Multiple sclerosis (Houndmills, Basingstoke, England). https://doi.org/10.1177/13524585251405101
Source records
- pubmed · retrieved 2026-09-25T10:56:05.962Z